The ZEISS Cirrus Pathfinder is now approved by the Therapeutic Goods Administration and available for sale in Australia. In this short video, Scott Dunn, Senior Product Specialist at ZEISS, describes how Cirrus Pathfinder, which has been trained on over 75,000 B-scans, uses deep learning algorithms to analyse B-scans, enabling more confident decision-making and improved analysis workflow.
